Recombinant zoster vaccine vs placebo
Cumulative incidence of herpes zoster at least 3.2 years · healthy older adults aged ≥ 60 years
Recombinant zoster vaccine probably leads to lower cumulative incidence of herpes zoster at least 3.2 years compared with placebo (moderate certainty).
1 finding from 1 review
- RR 0.08 [0.03, 0.23]2 studies · 22022 participantsModerate